Aisling Capital Management LP Obs Eva Sa Transaction History

Aisling Capital Management LP

  • $228 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$1.34 - $2.08 $529,082 - $821,263
-394,838 Closed
0 $0
Q1 2022

May 10, 2022
SELL
$1.1 - $2.17 $1.09 Million - $2.15 Million
-991,500 Reduced 71.52%
394,838 $596,000
Q4 2018

Feb 08, 2019
BUY
$10.8 - $17.94 $15 Million - $24.9 Million
1,386,338 New
1,386,338 $17.6 Million

Others Institutions Holding OBSV

# of Institutions
2
Shares Held
88K
Call Options Held
0
Put Options Held
0
View Full List

About ObsEva SA

OBSV Quotes by TradingView
  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Aisling Capital Management LP Portfolio

Follow Aisling Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aisling Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Aisling Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email